Case 98-3
History/Physical Findings:
A 35-year-old man with a history of AIDS presented with shortness of
breath. Chest x-ray showed clear lungs bilaterally without evidence of
lymphadenopathy. A large, left-sided pleural effusion was present.
Laboratory findings:
| |
Patient |
Normal Range |
|
|
Patient |
Normal Range |
| WBC |
4.6 |
(4.0-11.0) k/uL |
|
Neut % |
60.2 |
(47.0-82.0) % |
| RBC Count |
3.39 |
(4.6-6.2) M/uL |
|
Lymph % |
30.4 |
(15.0-45.0) % |
| Hemoglobin |
12.0 |
(14.0-18.0) g/dL |
|
Mono % |
8.0 |
(2.0-12.0) % |
| Hematocrit |
35.4 |
(40.0-52.0) % |
|
Eos % |
0.9 |
(0.0-6.0) % |
| MCV |
104.3 |
(83.0-95.0) fL |
|
Baso % |
0.6 |
(0.0-2.0) % |
| MCH |
35.3 |
(28.0-32.0) pg |
|
Neut # |
2.8 |
(1.8-8.0) k/uL |
| MCHC |
33.9 |
(32.0-36.0) g/dL |
|
Lymph # |
1.4 |
(1.0-5.0) k/uL |
| RDW |
13.4 |
(11.5-14.5) % |
|
Mono # |
0.4 |
(0.0-1.0) k/uL |
| Platelets |
150 |
(150-450) k/uL |
|
Eos # |
0.0 |
(0.0-0.6) k/uL |
|
|
|
|
Baso # |
0.0 |
(0.0-0.2) k/uL |
Microscopic examination of pleural fluid:


Flow cytometric analysis of pleural fluid:
| |
% |
| CD 19 |
5 |
| CD 5 |
15 |
| HLA-DR |
88 (strong) |
| CD 38 |
99 (strong) |
| CD 71 |
89 (strong) |
| CD 30 |
88 |
| CD 45 |
18 |
| CD 14 |
5 |
Immunohistochemically, the neoplasm is is negative for LCA
(Figure 2A). It is positive for epithelial membrane
antigen (Figure 2B). It

Further evaluation showed no evidence of lymphadenopathy or mass
lesions. A bone marrow biopsy showed an active cellular marrow and no
evidence of malignancy.
What is your diagnosis?
Discussion:
Primary effusion lymphomas related to AIDS were first recognized as a
distinct clinicopathologic entity by Walts and colleagues in
19901. Recent reports have further defined the features of
this entity,2,3 and demonstrated a relationship with
Epstein-Barr virus (EBV) and the recently described Kaposi's
sarcoma-associated herpesvirus (KSHV).
Microscopic examination of the pleural fluid showed a predominance
of very large, pleomorphic lymphocytes with enlarged nuclei, prominent,
frequently multiple nucleoli, and moderate to abundant deeply
basophilic cytoplasm which often contained vacuoles (Figure
1A-1C). By flow cytometry, the cells were negative for CD 45
(leucocyte common antigen), the B-cell marker CD 19 and the T-cell
marker CD 5. The cells were positive for the activation markers HLA-DR,
CD 38, CD 71 and CD 30. Paraffin-based immunohistochemical stains
performed on cell block material demonstrated positivity for CD 30 and
epithelial membrane antigen (Figure 2B), and absence
of staining for CD 45 (Figure 2A), the B-cell markers
L26 (CD 20), 4kb5 (CD 45RA), and the T-cell markers CD3p and UCHL-1 (CD
45RO).
Southern blot analysis was used to assess the immunoglobulin heavy
chain gene for evidence of clonal rearrangement using three separate
restriction enzymes. A single abnormal band was identified with each
enzyme. However, the band was heavier than the germ line band, and thus
the possibility that this was a result of partial digestion of the DNA,
rather than a gene rearrangement, could not be excluded. Southern blot
analysis demonstrated no evidence of clonal rearrangement of the T-cell
receptor beta gene. PCR analysis for the presence of EBV and KSHV
demonstrated the presence of KSHV and the absence of EBV in the tumor
cells.
The clinical, morphologic and immunophenotypic findings are
indicative of AIDS-related primary effusion lymphoma
(PEL).2,3 Typically, these lymphomas express LCA both by
immunocytochemistry and flow cytometry and activation antigens, but are
negative for B- and T-cell markers by flow cytometry and paraffin
immunohistochemistry. Rearrangement of immunoglobulin genes can usually
be detected via Southern blot analysis, indicating the B-cell nature of
these neoplasms. The lack of B-cell surface antigens and expression of
activation antigens most closely resembles the immunophenotype of
B-cells in the process of transformation to plasma cells among the
normal hematopoietic cell types. Unusual findings in this case include
the lack of positivity for LCA and EBV. These lymphomas occur almost
exclusively in men, and particularly homosexual men, with advanced
AIDS. These epidemiologic findings are very similar to those for
Kaposi's sarcoma. Kaposi's sarcoma is present in about one-third of
patients, and was present in this case. There is often no other
evidence of disease, and these lymphomas usually stay confined to body
cavities without disseminating to other sites. Median survival in the
largest series was five months (range: 12 days - 14 months), and did
not seem influenced by chemotherapy.
PELs should be distinguished from Burkitt-type lymphomas
(Figure 3B) that also occur in AIDS
patients2. In contrast to the marked cellular pleomorphism
of PELs, Burkitt-type lymphomas are relatively monomorphic. In
addition, the cells are smaller, with less prominent (and more often
multiple) nucleoii, and the cytoplasmic vacuoles are more frequently
seen. Burkitt-type lymphomas will also frequently have a B-cell
immunophenotype and express surface immunoglobulin. At the molecular
level, Burkitt-type lymphomas show amplification of the c-myc oncogene
and rearrangement of the bcl-6 oncogene, both of which are absent in
PELs. Finally, PELs contain KSHV sequences which are not present in
Burkitt-type lymphomas.
The patient refused chemotherapy for treatment of the lymphoma. One
year later, a biopsy of his axillary lymph node was reported as
follicular hyperplasia. Two years later, the patient developed a
pericardial effusion and enlarged groin lymph nodes. The microscopic
examination of the pericardial fluid reveals lymphoma cells similar to
those in his previous pleural fluid. Flow cytometry of the pericardial
effusion is shown below.

The flow cytometric analysis of his groin lymph node is very similar to
the results of his previous pleural fluid.
Flow cytometric analysis of pericardial fluid:
| |
% |
| CD 2 |
93 (weak) |
| CD 3 |
0 |
| CD 3+4 |
0 |
| CD 3+8 |
0 |
| CD 19 |
0 |
| CD 5 |
0 |
| HLA-DR |
76 |
| CD 38 |
99 (strong) |
| CD 71 |
89 (strong) |
| CD 30 |
88 |
| CD 45 |
18 |
| CD 14 |
5 |
Diagnosis:
AIDS-Related Primary Effusion Lymphoma
References:
- Walts AE, Shintaku P, Said JW. Diagnosis of malignant lymphoma in
effusions from patients with AIDS by gene rearrangement. Am J Clin
Pathol 1990;94:170-175.
- Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma:
A distinct clinicopathologic entity associated with the Kaposi's
sarcoma-associatated herpes virus. Blood 1996;88:645-656.
- Ansari MQ, Dawson DB, Nador R, et al. Primary body-cavity-based
AIDS-related lymphomas. Am J Clin Pathol 1996;105:221-229.
Contributors:
Linxi Li, M.D.
Department of Pathology
University of Virginia Health System
Kenneth Ries, M.D.
Department of Pathology
University of Virginia Health System
Brian J. Kolar, M.D.
Department of Pathology
University of Virginia Health System
Donald J. Innes, Jr., M.D.
Department of Pathology
University of Virginia Health System
Mark H. Stoler, M.D.
Department of Pathology
University of Virginia Health System
Questions should be addressed to:
dji@Virginia.EDU
|